Grupo BMH

Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home

  • FocalView is a first-of-its-kind app designed to modernize ophthalmic clinical trials, making them more accessible and flexible
     
  • Using patients' self-recorded measurements, FocalView aims to enable more sensitive trial endpoints and more accurate patient-reported outcomes
     
  • Using the Apple ResearchKit platform, Novartis is making FocalView vision tests freely available to the scientific community

Basel, April 25, 2018 - Novartis announced the launch of its FocalView app, an ophthalmic digital ...

25 April 2018    Subscribirse

Celebrating Community Partnership Day

Our first global Community Partnership Day was held in 1997. More than two decades later, volunteerism and giving back to communities where we live and work are more than just tradition; they’re core values.

Community Partnership Day is a powerful opportunity for our associates around the world to give back to their communities. In 2018, more than 23 900 Novartis associates from six continents and 58 countries are volunteering more than 191 200 hours of combined community service.

This year’s Community Partnership Day is taking place on April 24. We encourage everyone involved ...

24 April 2018    Subscribirse

African experts call for renewed global drive to beat malaria

African health experts warn that major advances in tackling malaria have led to widespread complacency and they are calling for a renewed effort to combat the disease.

Although global malaria deaths fell more than 60% between 2000 and 2015, experts participating in a recent survey said they fear progress could stall unless national governments provide more funding, and international organizations target their support more effectively. They point to mounting evidence that mosquitoes are becoming resistant to insecticides, and that malaria parasites are developing resistance to current ...

23 April 2018    Subscribirse

Two decades of volunteering at Novartis

For more than 20 years, Novartis employees the world over have been stepping out of the lab and away from their desks to come together in support of causes in their local communities.

Whether offering time and services for Community Partnership Day or providing continued support to a favored charity, the culture of volunteerism is a fundamental part of the Novartis corporate ethos.

Here’s a snapshot of our efforts over the years. For photos of this year’s volunteering efforts around the world, ...

20 April 2018    Subscribirse

New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients

  • Analyses of the EXPAND study showed that siponimod (BAF312) reduced the risk of disability progression largely disassociated from relapses in patients with secondary progressive multiple sclerosis (SPMS)[1]
     
  • In EXPAND, siponimod also had a meaningful benefit on patients' cognitive processing speed[2]
     
  • Findings add to clinical evidence for siponimod in SPMS, an area with a high unmet need for well-tolerated and effective new therapies[3]

Basel, April 20, 2018 - Novartis today announced new ...

20 April 2018    Subscribirse